BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
10/9/2026 8:15:18 AM | Browse: 1 | Download: 4
 |
Received |
|
2026-02-24 06:41 |
|
Peer-Review Started |
|
2026-02-24 06:47 |
|
First Decision by Editorial Office Director |
|
2026-05-08 08:08 |
|
Return for Revision |
|
2026-05-08 08:08 |
|
Revised |
|
2026-06-01 09:45 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2026-06-29 02:21 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-06-29 05:19 |
|
Articles in Press |
|
2026-06-29 05:19 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-07-08 06:48 |
|
Publish the Manuscript Online |
|
2026-10-09 08:15 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Correspondence |
| Article Title |
Letter to the Editor: Imaging biomarkers in rectal cancer - are we ready for clinical implementation?
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Melek Yakar |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Melek Yakar, Associate Professor, Department of Radiation Oncology, Eskisehir Osmangazi University Faculty of Medicine, Odunpazarı, Eskisehir 26480, Türkiye. mcakcay@ogu.edu.tr |
| Key Words |
Rectal cancer; Neoadjuvant chemoradiotherapy; Mesorectal fascia; Treatment response; Sarcopenia |
| Core Tip |
This article reviews a recent study examining the prognostic value of imaging parameters prior to neoadjuvant chemoradiotherapy in rectal cancer. It highlights that sarcopenia is not an independent predictor of oncological outcomes, whereas radiological image-based parameters, such as tumor length, mesorectal fascia involvement, and nodal involvement, are significantly associated with oncological outcomes. These findings support the importance of pre-treatment imaging biomarkers in predicting oncological outcomes, and their clinical implications are discussed in the context of the current literature. |
| Publish Date |
2026-10-09 08:15 |
| Citation |
Yakar M. Letter to the Editor: Imaging biomarkers in rectal cancer - are we ready for clinical implementation? World J Gastrointest Oncol 2026; 18(10): 120231
|
| URL |
https://www.wjgnet.com/1948-5204/full/v18/i10/120231.htm |
| DOI |
https://doi.org/10.4251/wjgo.120231 |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.
